Lv1
38 积分 2022-05-01 加入
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
1小时前
待确认
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
7天前
已完结
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial
10天前
已完结
肝细胞癌新辅助及转化治疗后疗效病理学评估专家共识（2025版）
13天前
已完结
原发性肝细胞癌后线规范化用药专家共识
5个月前
已关闭
Phosphoproteomics delineates hepatocellular carcinoma subtypes and pinpoints therapeutic targets
5个月前
已关闭
Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy
5个月前
已完结
Phosphoproteomics delineates hepatocellular carcinoma subtypes and pinpoints therapeutic targets
5个月前
已完结
原发性肝癌合并肝静脉/下腔静脉癌栓的综合治疗策略
7个月前
已完结
Multiparametric MRI-based Machine Learning Radiomics for Predicting Treatment Response to Transarterial Chemoembolization Combined with Targeted and Immunotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Study
8个月前
已完结
皖公网安备34019202002308
